About Endologix

Endologix develops and manufactures minimally invasive treatments for aortic disorders. Endologix's flagship product is the Powerlink(R) System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S.

website icon
Website
employees icon
Employees
industry icon
Industry
IT Services and IT Consulting
location icon
Headquarter
Irvine, CA
description icon
Founded
Unkn

Endologix Alternatives

Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics

Frequently Asked Questions about Endologix

Who are the decision makers in Endologix?

The decision makers in Endologix are Amritpal Chohan, Chip Richter, Chris Leach, etc. Click to Find Endologix decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more